The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Open accessAbstract
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological processes in the human body. In the last decade, considerable interest in galectin-3 has emerged because of its potential role as a biotarget. Galectin-3 is differentially expressed depending on the tissue type, however its expression can be induced under conditions of tissue injury or stress. Galectin-3 overexpression and secretion is associated with several diseases and is extensively studied in the context of fibrosis, heart failure, atherosclerosis and diabetes mellitus. Monomeric (extracellular) galectin-3 usually undergoes further "activation" which significantly broadens the spectrum of biological activity mainly by modifying its carbohydrate-binding properties. Self-interactions of this protein appear to play a crucial role in regulating the extracellular activities of this protein, however there is limited and controversial data on the mechanisms involved. We therefore summarize (recent) literature in this area and describe galectin-3 from a binding perspective providing novel insights into mechanisms by which galectin-3 is known to be "activated" and how such activation may be regulated in pathophysiological scenarios.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Self-citationGalectins: A family of animal β-galactoside-binding lectins
Barondes, S. H., Castronovo, V., Cooper, D. N. W., Cummings, R. D., Drickamer, K., Felzi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K.-I., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90498-7 · Cited by 1,223
Self-citationGalectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Sharma, U. C., Pokharel, S., van Brakel, T. J., van Berlo, J. H., Cleutjens, J. P. M., Schroen, B., André, S., Crijns, H. J. G. M., Gabius, H. J., Maessen, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000147181.65298.4d · Cited by 947
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
Expression of galectin-3 modulates T-cell growth and apoptosis.
Yang, R. Y., Hsu, D. K., & Liu, F. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6737 · Cited by 789
Self-citationDrickamer, K., & Taylor, M. E. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.001321 · Cited by 775
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., & Sethi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511167103 · Cited by 625
Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community
Ho, J. E., Liu, C., Lyass, A., Courchesne, P., Pencina, M. J., Vasan, R. S., Larson, M. G., & Levy, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.053 · Cited by 589
Self-citationGalectin-3 Expression and Secretion Links Macrophages to the Promotion of Renal Fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Kipari, T., Haslett, C., Iredale, J. P., Liu, F.-T., Hughes, J., & Sethi, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070726 · Cited by 562
Self-citationRegulation of Alternative Macrophage Activation by Galectin-3
MacKinnon, A. C., Farnworth, S. L., Hodkinson, P. S., Henderson, N. C., Atkinson, K. M., Leffler, H., Nilsson, U. J., Haslett, C., Forbes, S. J., & Sethi, T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2650 · Cited by 543
The regulation of inflammation by galectin‐3
Henderson, N. C., & Sethi, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00794.x · Cited by 522
Human Galectin-3 Is a Novel Chemoattractant for Monocytes and Macrophages
Sano, H., Hsu, D. K., Yu, L., Apgar, J. R., Kuwabara, I., Yamanaka, T., Hirashima, M., & Liu, F.-T. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.2156 · Cited by 521
Self-citationAhmad, N., Gabius, H.-J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., & Brewer, C. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312834200 · Cited by 517
Regulation of Transforming Growth Factor-β1–driven Lung Fibrosis by Galectin-3
MacKinnon, A. C., Gibbons, M. A., Farnworth, S. L., Leffler, H., Nilsson, U. J., Delaine, T., Simpson, A. J., Forbes, S. J., Hirani, N., Gauldie, J., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-0965oc · Cited by 516
Galectins: A Family of Animal Lectins That Decipher Glycocodes
Kasai, K.-I., & Hirabayashi, J. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021192 · Cited by 478
Metabolism, Cell Surface Organization, and Disease
Dennis, J. W., Nabi, I. R., & Demetriou, M. (2009) · Cell · doi:10.1016/j.cell.2009.12.008 · Cited by 450
Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis
Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., & Raz, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64959-0 · Cited by 446
Brewer, C. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00364-0 · Cited by 435
Yu, L., Ruifrok, W. P. T., Meissner, M., Bos, E. M., van Goor, H., Sanjabi, B., van der Harst, P., Pitt, B., Goldstein, I. J., Koerts, J. A., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.971168 · Cited by 435
Self-citationCritical role of galectin-3 in phagocytosis by macrophages
Sano, H., Hsu, D. K., Apgar, J. R., Yu, L., Sharma, B. B., Kuwabara, I., Izui, S., & Liu, F.-T. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317592 · Cited by 429
Ho, M. K., & Springer, T. A. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.128.3.1221 · Cited by 426
The fibrosis marker galectin‐3 and outcome in the general population
de Boer, R. A., van Veldhuisen, D. J., Gansevoort, R. T., Muller Kobold, A. C., van Gilst, W. H., Hillege, H. L., Bakker, S. J. L., & van der Harst, P. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02476.x · Cited by 376
Self-citationThe galectin lattice at a glance
Nabi, I. R., Shankar, J., & Dennis, J. W. (2015) · Journal of Cell Science · doi:10.1242/jcs.151159 · Cited by 329
Yu, F., Finley, R. L., Raz, A., & Kim, H.-R. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200154200 · Cited by 308
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Li, P., Liu, S., Lu, M., Bandyopadhyay, G., Oh, D., Imamura, T., Johnson, A. M. F., Sears, D., Shen, Z., Cui, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.025 · Cited by 297
Sato, S., & Hughes, R. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50525-7 · Cited by 270
Liu, Y.-H., D'Ambrosio, M., Liao, T.-D., Peng, H., Rhaleb, N.-E., Sharma, U., André, S., Gabius, H.-J., & Carretero, O. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2008 · Cited by 269
Hsu, D. K., Zuberi, R. I., & Liu, F. T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49693-2 · Cited by 264
Self-citationL-29, an endogenous lectin, binds to glycoconjugate ligands with positive cooperativity
Massa, S. M., Cooper, D. N. W., Leffler, H., & Barondes, S. H. (1993) · Biochemistry · doi:10.1021/bi00052a033 · Cited by 262
The Mac-2 antigen is a galactose-specific lectin that binds IgE.
Cherayil, B. J., Weiner, S. J., & Pillai, S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.1959 · Cited by 247
Papaspyridonos, M., McNeill, E., de Bono, J. P., Smith, A., Burnand, K. G., Channon, K. M., & Greaves, D. R. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.159160 · Cited by 236
Regulation of Cellular Adhesion to Extracellular Matrix Proteins by Galectin-3
Ochieng, J., Leite-Browning, M. L., & Warfield, P. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8708 · Cited by 230
Nieminen, J., Kuno, A., Hirabayashi, J., & Sato, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m604506200 · Cited by 229
Takenaka, Y., Fukumori, T., Yoshii, T., Oka, N., Inohara, H., Kim, H.-R. C., Bresalier, R. S., & Raz, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4395-4406.2004 · Cited by 228
Galectin–glycan lattices regulate cell-surface glycoprotein organization and signalling
Garner, O. B., & Baum, L. G. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361472 · Cited by 226
Galectin-3, a Novel Binding Partner of β-Catenin
Shimura, T., Takenaka, Y., Tsutsumi, S., Hogan, V., Kikuchi, A., & Raz, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1816 · Cited by 226
van der Velde, A. R., Gullestad, L., Ueland, T., Aukrust, P., Guo, Y., Adourian, A., Muntendam, P., van Veldhuisen, D. J., & de Boer, R. A. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000129 · Cited by 216
Self-citationThe Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Calvier, L., Martinez-Martinez, E., Miana, M., Cachofeiro, V., Rousseau, E., Sádaba, J. R., Zannad, F., Rossignol, P., & López-Andrés, N. (2015) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.08.002 · Cited by 215
Lok, D. J., Lok, S. I., Bruggink-André de la Porte, P. W., Badings, E., Lipsic, E., van Wijngaarden, J., de Boer, R. A., van Veldhuisen, D. J., & van der Meer, P. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-012-0500-y · Cited by 212
Self-citationGalectin-3 in angiogenesis and metastasis
Funasaka, T., Raz, A., & Nangia-Makker, P. (2014) · Glycobiology · doi:10.1093/glycob/cwu086 · Cited by 211
Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors
Traber, P. G., & Zomer, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083481 · Cited by 208
Sato, S., Burdett, I., & Hughes, R. C. (1993) · Experimental Cell Research · doi:10.1006/excr.1993.1157 · Cited by 199
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
Park, J. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.17.3595 · Cited by 198
Mehul, B., & Hughes, R. C. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.10.1169 · Cited by 193
Demotte, N., Wieërs, G., Van Der Smissen, P., Moser, M., Schmidt, C., Thielemans, K., Squifflet, J.-L., Weynand, B., Carrasco, J., Lurquin, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0761 · Cited by 179
Pejnovic, N. N., Pantic, J. M., Jovanovic, I. P., Radosavljevic, G. D., Milovanovic, M. Z., Nikolic, I. G., Zdravkovic, N. S., Djukic, A. L., Arsenijevic, N. N., & Lukic, M. L. (2013) · Diabetes · doi:10.2337/db12-0222 · Cited by 172
Galectin‐3 regulates T‐cell functions
Hsu, D. K., Chen, H., & Liu, F. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00798.x · Cited by 166
Self-citationChauhan, D., Li, G., Podar, K., Hideshima, T., Neri, P., He, D., Mitsiades, N., Richardson, P., Chang, Y., Schindler, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0163 · Cited by 164
Martínez-Martínez, E., Calvier, L., Fernández-Celis, A., Rousseau, E., Jurado-López, R., Rossoni, L. V., Jaisser, F., Zannad, F., Rossignol, P., Cachofeiro, V., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05876 · Cited by 163
Menon, R. P., & Hughes, R. C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00671.x · Cited by 163
Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
Karlsson, A., Christenson, K., Matlak, M., Bjorstad, A., Brown, K. L., Telemo, E., Salomonsson, E., Leffler, H., & Bylund, J. (2008) · Glycobiology · doi:10.1093/glycob/cwn104 · Cited by 163
Ligand Induced Galectin-3 Protein Self-association
Lepur, A., Salomonsson, E., Nilsson, U. J., & Leffler, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.c112.358002 · Cited by 158
Gao, X., Zhi, Y., Sun, L., Peng, X., Zhang, T., Xue, H., Tai, G., & Zhou, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.482315 · Cited by 154
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
MacKinnon, A. C., Liu, X., Hadoke, P. W. F., Miller, M. R., Newby, D. E., & Sethi, T. (2013) · Glycobiology · doi:10.1093/glycob/cwt006 · Cited by 148
Kolatsi‐Joannou, M., Price, K. L., Winyard, P. J. D., & Long, D. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018683 · Cited by 146
Hsu, D. K., Hammes, S. R., Kuwabara, I., Greene, W. C., & Liu, F. T. (1996) · Europe PMC (PubMed Central) · Cited by 138
Self-citationStreetly, M. J., Maharaj, L., Joel, S., Schey, S., Gribben, J. G., & Cotter, F. E. (2010) · Blood · doi:10.1182/blood-2009-10-251660 · Cited by 133
John, C. M., Leffler, H., Kahl‐Knutsson, B., Svensson, I., & Jarvis, G. A. (2003) · PubMed · Cited by 130
Nachtigal, M., Ghaffar, A., & Mayer, E. P. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070348 · Cited by 129
Mac-2-binding glycoproteins. Putative ligands for a cytosolic beta-galactoside lectin.
Rosenberg, I. M., Cherayil, B. J., Isselbacher, K. J., & Pillai, S. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55124-3 · Cited by 126
Expression and immunohistochemical localization of galectin‐3 in various mouse tissues
Kim, H., Lee, J., Hyun, J. W., Park, J. W., Joo, H., & Shin, T. (2006) · Cell Biology International · doi:10.1016/j.cellbi.2006.11.036 · Cited by 114
Sathisha, U. V., Jayaram, S., Nayaka, M. A. H., & Dharmesh, S. M. (2007) · Glycoconjugate Journal · doi:10.1007/s10719-007-9042-3 · Cited by 114
Galectin-3 in Heart Failure with Preserved Ejection Fraction
de Boer, R. A., Edelmann, F., Solal, A. C., Mamas, M. A., Maisel, A. S., & Pieske, B. M. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft077 · Cited by 112
TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor
Kim, Y.-W., Park, J., Lee, H., Lee, S., & Kim, S. (2012) · Biochemical Journal · doi:10.1042/bj20111923 · Cited by 110
Galectin-3 Accelerates M2 Macrophage Infiltration and Angiogenesis in Tumors
Jia, W., Kidoya, H., Yamakawa, D., Naito, H., & Takakura, N. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.017 · Cited by 108
Increased Adiposity, Dysregulated Glucose Metabolism and Systemic Inflammation in Galectin-3 KO Mice
Pang, J., Rhodes, D., Pini, M., Akasheh, R. T., Castellanos, K. J., Cabay, R. J., Cooper, D., Perretti, M., & Fantuzzi, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057915 · Cited by 106
Hsieh, T.-J., Lin, H., Tu, Z., Lin, T.-C., Wu, S., Tseng, Y., Liu, F., Hsu, S. D., & Lin, C. (2016) · Scientific Reports · doi:10.1038/srep29457 · Cited by 104
Self-citationUncoupling of Chondrocyte Death and Vascular Invasion in Mouse Galectin 3 Null Mutant Bones
Colnot, C., Sidhu, S., BALMAIN, N., et al. (2001) · Developmental Biology · doi:10.1006/dbio.2000.9933 · Cited by 103
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander?
Desmedt, V., Desmedt, S., Delanghe, J., Speeckaert, R., & Speeckaert, M. M. (2016) · American Journal of Nephrology · doi:10.1159/000446376 · Cited by 101
Ortéga, N., Behonick, D. J., Colnot, C., Cooper, D. N. W., & Werb, Z. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1119 · Cited by 96
Novak, R., Dabelić, S., & Dumić, J. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.11.014 · Cited by 93
Lin, Y.-H., Qiu, D.-C., Chang, W.-H., Yeh, Y., Jeng, U., Liu, F., & Huang, J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.802793 · Cited by 93
Self-citationDifferential expression of Galectin-1 and Galectin-3 during first trimester human embryogenesis
van den Brûle, F. A., Fernández, P. L., Buicu, C., Liu, F.-T., Jackers, P., Lambotte, R., & Castronovo, V. (1997) · Developmental Dynamics · Cited by 92
Self-citationStructure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin.
Méhul, B., Bawumia, S., Martin, S. R., & Hughes, R. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32441-9 · Cited by 89
The Role of Galectin-3 in Promotion of the Inflammatory Response
Liu, F., & Hsu, D. K. (2007) · Drug News & Perspectives · doi:10.1358/dnp.2007.20.7.1149628 · Cited by 89
Self-citationLiu, F., Hsu, D. K., Zuberi, R. I., Hill, P. N., Shenhav, A., Kuwabara, I., & Chen, S.-S. (1996) · Biochemistry · doi:10.1021/bi952716q · Cited by 89
Self-citationExpression of Galectin-3 in Skeletal Tissues Is Controlled by Runx2
Stock, M., Schäfer, H. S., Stricker, S., Groß, G., Mundlos, S., & Otto, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207631200 · Cited by 89
Nuclear transport of galectin-3 and its therapeutic implications
Funasaka, T., Raz, A., & Nangia‐Makker, P. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.004 · Cited by 88
Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR
Ippel, H., Miller, M. C., Vértesy, S., Zheng, Y., Cañada, F. J., Suylen, D. P. L., Umemoto, K., Romanò, C., Hackeng, T. M., Tai, G., et al. (2016) · Glycobiology · doi:10.1093/glycob/cww021 · Cited by 88
Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
Martínez‐Martínez, E., López‐Andrés, N., Jurado-López, R., Rousseau, E., Bartolomé, M. V., Fernández‐Celis, A., Rossignol, P., Islas, F., Antequera-Pérez, A., Prieto, S., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06032 · Cited by 86
LPS-Induced Galectin-3 Oligomerization Results in Enhancement of Neutrophil Activation
Fermino, M. L., Polli, C. D., Toledo, K. A., Liu, F., Hsu, D. K., Roque‐Barreira, M. C., Pereira-da-Silva, G., Bernardes, E. S., & Halbwachs‐Mecarelli, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026004 · Cited by 84
Self-citationMonaco, S., Sparano, V., Gioia, M., Sbardella, D., Pierro, D. D., Marini, S., & Coletta, M. (2006) · Protein Science · doi:10.1110/ps.062430706 · Cited by 83
Gonzalez, G. E., Cassaglia, P., Truant, S. N., Fernández, M. M., Wilensky, L., Volberg, V. I., Malchiodi, E. L., Morales, C., & Gelpi, R. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.011 · Cited by 79
He, J., Li, X., Luo, H., Li, T., Zhao, L., Qi, Q., Liu, Y., & Yu, Z. (2017) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2017.03.008 · Cited by 78
Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor
Saint-Lu, N., Oortwijn, B. D., Pegon, J. N., Odouard, S., Christophe, O. D., de Groot, P. G., Denis, C. V., & Lenting, P. J. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.240309 · Cited by 77
Fowlis, D. J., Colnot, C., Ripoche, M., & Poirier, F. (1995) · Developmental Dynamics · doi:10.1002/aja.1002030211 · Cited by 75
Analysis of the neutral polysaccharide fraction of MCP and its inhibitory activity on galectin-3
Gao, X., Zhi, Y., Zhang, T., Xue, H., Wang, X., Foday, A. D., Tai, G., & Zhou, Y. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9382-5 · Cited by 75
Cheng, H., Zhang, Z., Leng, J., Liu, D., Hao, M., Gao, X., Tai, G., & Zhou, Y. (2012) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637486.2012.694853 · Cited by 75
Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension
Gonzalez, G. E., Rhaleb, N., D’Ambrosio, M. A., Nakagawa, P., Liao, T., Peterson, E. L., Leung, P., Dai, X., Janic, B., Liu, Y.-H., et al. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00096.2016 · Cited by 75
Chen, W., Cao, Z., Leffler, H., Nilsson, U. J., & Panjwani, N. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20009 · Cited by 74
Sundblad, V., Croci, D. O., & Rabinovich, G. A. (2011) · PubMed · doi:10.14670/hh-26.247 · Cited by 73
Galectin-3: A Modifiable Risk Factor in Heart Failure
de Boer, R. A., van der Velde, A. R., Mueller, C. E., van Veldhuisen, D. J., Anker, S. D., Peacock, W. F., Adams, K. F., & Maisel, A. S. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6520-2 · Cited by 73
Kim, K., Mayer, E. P., & Nachtigal, M. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00045-4 · Cited by 73
Wu, C., Su, M.-Y. M., Lee, J.-K., Chiang, F., Hwang, J., Lin, J.-L., Chen, J.-J., Liu, F., & Tsai, C. (2015) · Scientific Reports · doi:10.1038/srep17007 · Cited by 73
Self-citationDalton, P., Christian, H., Redman, C. W. G., Sargent, I. L., & Boyd, C. A. R. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05806.x · Cited by 72
Larsen, L. N., Chen, H., Saegusa, J., & Liu, F. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.07.008 · Cited by 72
Self-citationvan Hattum, H., Branderhorst, H. M., Moret, E. E., Nilsson, U. J., Leffler, H., & Pieters, R. J. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301677r · Cited by 71
Miller, M. C., Ippel, H., Suylen, D. P. L., Klyosov, A. A., Traber, P. G., Hackeng, T. M., & Mayo, K. H. (2015) · Glycobiology · doi:10.1093/glycob/cwv073 · Cited by 71
Tubular Atrophy and Interstitial Fibrosis After Renal Transplantation Is Dependent on Galectin-3
Dang, Z., MacKinnon, A. C., Marson, L., & Sethi, T. (2012) · Transplantation · doi:10.1097/tp.0b013e318242f40a · Cited by 70
Lunde, I. G., Herum, K. M., Carlson, C. R., & Christensen, G. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2454-2 · Cited by 69
Birdsall, B., Feeney, J., Burdett, I. D. J., et al. (2001) · Biochemistry · doi:10.1021/bi002907f · Cited by 67
Barboni, E., Bawumia, S., Henrick, K., & Hughes, R. C. (2000) · Glycobiology · doi:10.1093/glycob/10.11.1201 · Cited by 67
Mirandola, L., Yu, Y., Chui, K. K., Jenkins, M., Cobos, E., John, C. M., & Chiriva‐Internati, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021811 · Cited by 66
Demotte, N., Bigirimana, R., Wieërs, G., Stroobant, V., Squifflet, J.-L., Carrasco, J., Thielemans, K., Baurain, J., Smissen, P. V. D., Courtoy, P. J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2459 · Cited by 66
Stegmayr, J., Lepur, A., Kahl-Knutson, B., Aguilar‐Moncayo, M., Klyosov, A. A., Field, R. A., Oredsson, S., Nilsson, U. J., & Leffler, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.721464 · Cited by 66
Li, Y.-J., Kukita, A., Teramachi, J., Nagata, K., Wu, Z., Akamine, A., & Kukita, T. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.111 · Cited by 62
The second intron of the human galectin‐3 gene has a strong promoter activity down‐regulated by p53
Raimond, J., Rouleux‐Bonnin, F., Monsigny, M. L. P., & Legrand, A. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00310-6 · Cited by 57
Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
Böcker, S., Laaf, D., & Elling, L. (2015) · Biomolecules · doi:10.3390/biom5031671 · Cited by 53
Pharmacological inhibition of galectin-3 protects against hypertensive nephropathy
Frenay, A.-R. S., Yu, L., van der Velde, A. R., Vreeswijk‐Baudoin, I., López‐Andrés, N., van Goor, H., Silljé, H. H. W., Ruifrok, W.-P. T., & de Boer, R. A. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00461.2014 · Cited by 53
Self-citationDuckworth, C. A., Guimond, S. E., Sindrewicz, P., Hughes, A. J., French, N. S., Lian, L., Yates, E. A., Pritchard, D. M., Rhodes, J. M., Turnbull, J. E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4409 · Cited by 53
Galectin-3, a Novel Centrosome-associated Protein, Required for Epithelial Morphogenesis
Koch, A., Poirier, F., Jacob, R., & Delacour, D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-03-0193 · Cited by 51
Hamann, K. K., Cowles, E. A., Wang, J. L., & Anderson, R. L. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90458-7 · Cited by 49
Drickamer, K. (1993) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.9.1.237 · Cited by 47
Talaga, M. L., Fan, N., Fueri, A. L., Brown, R. K., Bandyopadhyay, P., & Dam, T. K. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00504 · Cited by 44
Akimoto, Y., Ikehara, S. K., Yamaguchi, T., Kim, J., Kawakami, H., Shimizu, N., Hori, M., Sakakita, H., & Ikehara, Y. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.01.012 · Cited by 42
G3-C12 Peptide Reverses Galectin-3 from Foe to Friend for Active Targeting Cancer Treatment
Sun, W. Y., Li, L., Yang, Q., Shan, W., Zhang, Z., & Huang, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00568 · Cited by 40
Michel, A. K., Nangia‐Makker, P., Raz, A., & Cloninger, M. J. (2014) · ChemBioChem · doi:10.1002/cbic.201402134 · Cited by 37
Galectin-1 and Galectin-3 Constitute Novel-Binding Partners for Factor VIII
O’Sullivan, J. M., Jenkins, P. V., Rawley, O., Gegenbauer, K., Chion, A., Lavin, M., Byrne, B. J., O’Kennedy, R. J., Preston, R. J. S., Brophy, T. M., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306915 · Cited by 32
Introduction to glycopathology: The concept, the tools and the perspectives
Gabius, H.-J., & Kayser, K. (2014) · Diagnostic Pathology · doi:10.1186/1746-1596-9-4 · Cited by 31
Galectin-3–null mice display defective neutrophil clearance during acute inflammation
Wright, R. D., Souza, P. R., Flak, M. B., Thedchanamoorthy, P., Norling, L. V., & Cooper, D. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0116-026rr · Cited by 30
A role for galectin-3 in CD13-mediated homotypic aggregation of monocytes
Mina‐Osorio, P., Soto‐Cruz, I., & Ortega, E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.081 · Cited by 29
Anti-Galectin-3 Therapy: A New Chance for Multiple Myeloma and Ovarian Cancer?
Mirandola, L., Nguyen, D. D. T., Rahman, R. L., Grizzi, F., Yu, Y., Figueroa, J. A., Jenkins, M., Cobos, E., & Chiriva‐Internati, M. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.911855 · Cited by 29
Knights, A. J., Yik, J. J., Jusoh, H. M., Norton, L. J., Funnell, A. P. W., Pearson, R. C. M., Bell-Anderson, K. S., Crossley, M., & Quinlan, K. G. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.715748 · Cited by 29
Cited by
Heart failure with preserved ejection fraction: from mechanisms to therapies
Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355
de Boer, R. A., De Keulenaer, G., Bauersachs, J., Brutsaert, D., Cleland, J. G., Diez, J., Du, X.-J., Ford, P., Heinzel, F. R., Lipson, K. E., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1406 · Cited by 304
Self-citationReview of galectin-3 inhibitors in the treatment of nonalcoholic steatohepatitis
Al Attar, A., Antaramian, A., & Noureddin, M. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1894127 · Cited by 47
Galectin-3 in Microglia-Mediated Neuroinflammation: Implications for Central Nervous System Diseases
Tian, Y.-K., Ye, D.-W., Ge, M.-M., Chen, N., Zhou, Y.-Q., & Yang, H. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220201094547 · Cited by 31
Metadata
- Authors
- Suthahar, N., Meijers, W. C., Silljé, H. H. W., Ho, J. E., Liu, F.-T., & de Boer, R. A.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2018
- Volume
- 8
- Issue
- 3
- Pages
- 593-609
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W2769708180
- Cited by
- 309
- References
- 126
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.